Wood K J, Evins J, Morris P J
Transplantation. 1985 Jan;39(1):56-62. doi: 10.1097/00007890-198501000-00006.
In the rat a single i.v. injection of donor whole blood (0.5 ml) 7 days before a renal allograft leads to complete suppression of rejection and permanent acceptance of the graft in DA(RT1a)-to-LEW(RT1(1], LEW-to-DA, and (DA X LEW)F1-to-DA combinations. This effect is donor-specific. Purified erythrocyte preparations were used for pretreatment (8 X 10(9) erythrocytes) 7 days before transplantation in the same strain combinations. The contamination by leukocytes was 1300 per 8 X 10(9) erythrocytes after one method of preparation, but only 1.3 per 8 X 10(9) erythrocytes after further purification by affinity chromatography. Both preparations of purified erythrocytes were able to suppress rejection and induce permanent acceptance of an allograft. The role of contaminating leukocytes in the first preparation was further excluded by pretreating rats with 1300 lymphocytes, but in these animals allografts were rejected in the normal fashion. The effect of the erythrocyte pretreatment was donor-specific, dose-dependent, only effective if given by the i.v. route, and not effective if given less than 7 days before transplantation. Furthermore neither lymphocytotoxic nor erythrocyte binding antibody could be detected in rats pretreated with purified erythrocytes. These experiments show convincingly that, in the rat--in the strain combinations tested--pretreatment with erythrocytes, that express cell surface class I MHC antigens, but not class II products, can induce specific suppression of rejection of a renal allograft.
在大鼠中,肾移植前7天单次静脉注射供体全血(0.5毫升)可导致DA(RT1a)至LEW(RT1l)、LEW至DA以及(DA×LEW)F1至DA组合中排斥反应完全受到抑制,移植物被永久接受。这种效应具有供体特异性。在相同品系组合的移植前7天,使用纯化的红细胞制剂进行预处理(8×10⁹个红细胞)。一种制备方法后,每8×10⁹个红细胞中的白细胞污染为1300个,但经亲和层析进一步纯化后,每8×10⁹个红细胞中仅为1.3个。两种纯化红细胞制剂均能够抑制排斥反应并诱导移植物的永久接受。通过用1300个淋巴细胞对大鼠进行预处理,进一步排除了第一种制剂中污染白细胞的作用,但在这些动物中,同种异体移植物以正常方式被排斥。红细胞预处理的效应具有供体特异性、剂量依赖性,仅静脉注射给药有效,移植前不到7天给药则无效。此外,在用纯化红细胞预处理的大鼠中未检测到淋巴细胞毒性抗体或红细胞结合抗体。这些实验令人信服地表明,在大鼠中——在所测试的品系组合中——用表达细胞表面I类MHC抗原而非II类产物的红细胞进行预处理,可诱导对肾同种异体移植排斥反应的特异性抑制。